Fortis Healthcare Limited
NSE:FORTIS.NS
590.5 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 68,929.2 | 62,976.3 | 56,386.471 | 39,613.346 | 45,068.733 | 43,868.704 | 45,608.096 | 45,271.474 | 42,191.712 | 39,330.504 | 36,276.593 | 42,026.845 | 29,840.372 | 14,829.706 | 9,379.384 | 6,305.448 | 5,070.952 | 5,123.539 | 2,925.53 | 737.26 | 491.43 | 388.65 | 118.85 |
| Cost of Revenue
| 45,402.2 | 27,661.7 | 14,179.767 | 18,440.133 | 20,220.795 | 21,574.731 | 19,742.169 | 20,713.615 | 20,312.024 | 19,034.905 | 17,148.775 | 13,766.73 | 6,895.394 | 3,929.836 | 2,626.721 | 1,895.384 | 1,615.142 | 1,772.7 | 1,032.87 | 271.95 | 179.54 | 150.65 | 53.97 |
| Gross Profit
| 23,527 | 35,314.6 | 42,206.704 | 21,173.213 | 24,847.938 | 22,293.973 | 25,865.927 | 24,557.859 | 21,879.688 | 20,295.599 | 19,127.818 | 28,260.115 | 22,944.978 | 10,899.87 | 6,752.663 | 4,410.064 | 3,455.81 | 3,350.839 | 1,892.66 | 465.31 | 311.89 | 238 | 64.88 |
| Gross Profit Ratio
| 0.341 | 0.561 | 0.749 | 0.534 | 0.551 | 0.508 | 0.567 | 0.542 | 0.519 | 0.516 | 0.527 | 0.672 | 0.769 | 0.735 | 0.72 | 0.699 | 0.681 | 0.654 | 0.647 | 0.631 | 0.635 | 0.612 | 0.546 |
| Reseach & Development Expenses
| 0 | 0 | 0.145 | 0.466 | 2.471 | 5.613 | 7.597 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,271.454 | 1,244.385 | 12,345.101 | 1,188.949 | 1,199.337 | 2,320.941 | 4,804.946 | 4,417.627 | 4,162.58 | 4,123.07 | 3,114.947 | 3,756.086 | 7,848.292 | 3,201.201 | 976.531 | 644.924 | 638.937 | 467.716 | 291.19 | 55.64 | 55.85 | 48.1 | 34.97 |
| Selling & Marketing Expenses
| 2,702.487 | 2,319.938 | 1,619.164 | 851.832 | 1,947.904 | 1,957.363 | 1,840.929 | 1,775.988 | 1,664.43 | 1,638.862 | 1,323.736 | 900.857 | 638.425 | 0 | 0 | 0 | 0 | 0 | 35.79 | 40.51 | 21.38 | 18.45 | 18.25 |
| SG&A
| 14,267.6 | 3,564.323 | 13,964.265 | 2,040.781 | 3,147.241 | 4,278.304 | 6,645.875 | 6,193.615 | 5,827.01 | 5,761.932 | 4,438.683 | 4,656.943 | 8,486.717 | 3,201.201 | 976.531 | 644.924 | 638.937 | 467.716 | 326.98 | 96.15 | 77.23 | 66.55 | 53.22 |
| Other Expenses
| 382.5 | 617.2 | 289.438 | 322.737 | 408.279 | 302.374 | 26.831 | 220.638 | 253.383 | 334.626 | 699.652 | 541.003 | -1.542 | 3,673.091 | 4,469.302 | 3,110.012 | 2,667.555 | 3,105.941 | 1,758.42 | 486.11 | 345.39 | 273.63 | 179.83 |
| Operating Expenses
| 14,267.6 | 27,458.6 | 34,761.558 | 20,207.056 | 21,805.005 | 22,151.553 | 25,047.54 | 23,368.515 | 22,144.685 | 21,256.074 | 20,401.137 | 27,410.384 | 20,563.44 | 6,874.292 | 5,445.833 | 3,754.936 | 3,306.492 | 3,573.657 | 2,085.4 | 582.26 | 422.62 | 340.18 | 233.05 |
| Operating Income
| 9,259.4 | 7,843.899 | 7,602.661 | 1,182.664 | 3,109.609 | 398.636 | 818.387 | 1,367.656 | -93.988 | -797.12 | -1,111.394 | 1,061.859 | 2,381.538 | 4,025.578 | 1,306.83 | 655.128 | 149.318 | -222.818 | -192.74 | -116.95 | -110.73 | -102.18 | -168.17 |
| Operating Income Ratio
| 0.134 | 0.125 | 0.135 | 0.03 | 0.069 | 0.009 | 0.018 | 0.03 | -0.002 | -0.02 | -0.031 | 0.025 | 0.08 | 0.271 | 0.139 | 0.104 | 0.029 | -0.043 | -0.066 | -0.159 | -0.225 | -0.263 | -1.415 |
| Total Other Income Expenses Net
| -774.8 | 355.16 | 2,275.208 | -749.71 | -716.017 | -1,499.65 | -9,936.097 | 4,149.237 | -141.772 | -798.273 | -1,432.692 | 5,925.658 | -1,303.935 | -2,499.918 | -572.818 | -436.607 | -554.774 | -660.043 | -343.23 | -53.85 | -82.24 | -95.08 | -96.6 |
| Income Before Tax
| 8,484.6 | 8,136.8 | 9,877.869 | 432.954 | 2,393.592 | -1,101.014 | -9,117.71 | 5,516.893 | -235.76 | -1,595.393 | -2,544.086 | 6,987.517 | 1,077.603 | 1,525.66 | 734.012 | 218.521 | -405.456 | -882.861 | -535.97 | -170.8 | -192.97 | -197.26 | -264.77 |
| Income Before Tax Ratio
| 0.123 | 0.129 | 0.175 | 0.011 | 0.053 | -0.025 | -0.2 | 0.122 | -0.006 | -0.041 | -0.07 | 0.166 | 0.036 | 0.103 | 0.078 | 0.035 | -0.08 | -0.172 | -0.183 | -0.232 | -0.393 | -0.508 | -2.228 |
| Income Tax Expense
| 2,127.5 | 1,807 | 1,978.415 | 994.641 | 1,478.708 | 1,136.132 | 226.51 | 724.004 | 465.677 | 45.31 | 166.458 | 1,873.906 | 408.46 | 152.386 | 33.563 | 41.091 | 195.49 | 72.794 | 114.07 | 26.06 | -124.14 | 3.12 | -29.81 |
| Net Income
| 5,988.755 | 5,887.308 | 5,551.185 | -1,097.618 | 579.359 | -2,989.383 | -10,092.169 | 4,216.647 | -248.517 | -1,436.997 | 1,225.424 | 4,999.36 | 722.215 | 1,243.634 | 694.814 | 208.189 | -554.835 | -981.159 | -577.02 | -85.83 | -68.83 | -200.38 | -234.96 |
| Net Income Ratio
| 0.087 | 0.093 | 0.098 | -0.028 | 0.013 | -0.068 | -0.221 | 0.093 | -0.006 | -0.037 | 0.034 | 0.119 | 0.024 | 0.084 | 0.074 | 0.033 | -0.109 | -0.192 | -0.197 | -0.116 | -0.14 | -0.516 | -1.977 |
| EPS
| 7.93 | 7.8 | 7.35 | -1.45 | 0.77 | -4.64 | -15.67 | 8.87 | -0.39 | -2.23 | 2.7 | 12.34 | 1.78 | 3.23 | 2.62 | 0.64 | -0.86 | -1.52 | -0.9 | -0.13 | -0.11 | -0.31 | -0.36 |
| EPS Diluted
| 7.93 | 7.8 | 7.35 | -1.45 | 0.77 | -4.64 | -15.67 | 8.87 | -0.39 | -2.23 | 2.7 | 12.33 | 1.78 | 3.23 | 2.61 | 0.64 | -0.86 | -1.52 | -0.9 | -0.13 | -0.11 | -0.31 | -0.36 |
| EBITDA
| 12,684.4 | 11,849 | 10,897.033 | 4,795.705 | 6,729.125 | 5,529.974 | 4,588.751 | 9,452.361 | 2,760.518 | 2,437.613 | 2,301.646 | 4,313.753 | 4,241.954 | 5,070.501 | 1,906.232 | 1,142.528 | 617.566 | 615.224 | 257.03 | -29.94 | -40.82 | -25.03 | -113.21 |
| EBITDA Ratio
| 0.184 | 0.188 | 0.193 | 0.121 | 0.149 | 0.126 | 0.101 | 0.209 | 0.065 | 0.062 | 0.063 | 0.103 | 0.142 | 0.342 | 0.203 | 0.181 | 0.122 | 0.12 | 0.088 | -0.041 | -0.083 | -0.064 | -0.953 |